Results for tag: "Budesonide Inhaler"

The Budesonide Inhaler market is a segment of the larger Respiratory Drugs market. It is composed of inhalers that contain budesonide, a corticosteroid used to treat asthma and other respiratory conditions. Budesonide inhalers are used to reduce inflammation in the airways, allowing for easier breathing. They are also used to prevent asthma attacks and reduce the severity of symptoms. Budesonide inhalers are available in both pressurized metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs). The Budesonide Inhaler market is highly competitive, with many companies offering different types of inhalers. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Merck, Teva Pharmaceuticals, and Mylan. Other companies such as Boehringer Ingelheim, Novartis, and Sunovion also offer budesonide inhalers. Show Less Read more